Vanderbilt-Ingram Cancer Center

02/25/2026

A lung cancer diagnosis can feel overwhelming and it is natural to have questions about what treatment will look like. Dr. Eric Grogan explains how your care team considers three important factors to guide your plan: the type of tumor, how far it has spread and your overall health.

At Vanderbilt-Ingram Cancer Center, specialists from many areas meet together to review each case and recommend the safest and most effective treatment options. Your plan may include surgery, chemotherapy, radiation, immunotherapy or a combination, based on what is best for you.

Every patient’s situation is unique. Understanding your options can help you feel more confident and supported as you make decisions about your care.

Read the full article from the link in the comments for more information.

02/24/2026

Our team of hematology oncologists are bringing new hope to patients with advanced melanoma through a newly launched tumor infiltrating lymphocyte (TIL) therapy program. This treatment uses a patient’s own immune cells to help the body fight cancer more effectively.

Dr. Olalekan Oluwole and Dr. Douglas Johnson are leading this program, and recently cared for the first patient to receive this therapy at Vanderbilt-Ingram Cancer Center. The patient’s melanoma had spread despite several previous treatments. Our surgeons collected immune cells from the tumor, the cells were expanded in a laboratory, and then they were infused back into the patient to strengthen their immune system’s response. More patients are now preparing to receive this therapy.

For those who have exhausted other treatments, this therapy provides a new path forward and the chance for long‑lasting benefit. This work builds on our leadership in advanced immunotherapies such as CAR-T and moves us closer to giving more patients more hope and more options.

02/20/2026

Join us on Saturday, April 18 at the Head for the Cure 5k Run/Walk. Hosting its first event in the greater Nashville area gives more people the opportunity to support the brain tumor community. If you’re in the area, come spend the best day of the year with us!

Funds raised will support the Vanderbilt-Ingram Cancer Center! Sign up now:
headforthecure.org/nashville

Head for the Cure is heading to Nashville!

Our Inaugural 5K Run/Walk - Nashville is scheduled for April 18th. Hosting our first event in the greater Nashville area gives more people the opportunity to support the brain tumor community. If you’re in the area, come spend the best day of the year with us!

Funds raised will support the Vanderbilt-Ingram Cancer Center! Sign up now:
headforthecure.org/nashville

02/18/2026

When Sallie Bailey lost her husband, John, to cholangiocarcinoma (bile duct cancer) just six months after his diagnosis, she turned her grief into purpose. John was a talented chef who worked in world-class kitchens and loved sharing his passion for food, wine and travel.

Sallie now honors his legacy by supporting research at Vanderbilt-Ingram Cancer Center with a clear goal to help researchers detect cholangiocarcinoma earlier, slow its progression and improve quality of life for patients.

Thanks to supporters like Sallie, this mission is bringing new hope to those facing this rare cancer.

02/18/2026

Join us for a virtual Lunch and Learn session on Wednesday, March 4 at noon with a panel of renowned experts from the Vanderbilt-Ingram Cancer Center.

During this session, Vanderbilt experts will share their insights and experiences treating patients with kidney cancer. You will have the chance to learn about new treatment options, research breakthroughs, and current clinical trial innovations. Register below.

Join us for a virtual Lunch and Learn session with a panel of renowned experts from the Vanderbilt-Ingram Cancer Center.

02/17/2026

We are so excited to announce our first Livestream Q&A for 2026!

Join us on Tuesday, February 24 at 7PM EST on NCANonYouTube.com for a live, patient-focused Q&A with two leading specialists from Vanderbilt University Medical Center — Dr. Robert Ramirez and Dr. Deyali Chatterjee — as they answer YOUR questions and discuss important topics in neuroendocrine cancer care!

02/13/2026

We are celebrating a major milestone at Vanderbilt Health as our team completes its 100th histotripsy treatment! This innovative, noninvasive approach is shaping the future of liver cancer care and expanding options for people facing liver tumors or liver metastases.

Histotripsy uses highly focused ultrasound waves to precisely destroy tumors without any incisions. The technology creates tiny bubbles inside the tumor tissue that rapidly expand and collapse. This process helps break apart the cancer while protecting the surrounding healthy areas of the liver.

Aaron Davis of Cleveland, Tennessee, experienced this firsthand during Vanderbilt Health's milestone procedure. After facing significant pain during previous cancer surgeries and having limited options for pain medication, he shared how life-changing it was to undergo treatment while avoiding the discomfort of an incision.

As one of the first centers in the nation to offer histotripsy, Vanderbilt‑Ingram Cancer Center is expanding safe, effective options for patients with liver cancer or liver metastases. Ask your provider whether histotripsy may be right for you.

Visit the link in the comments to read more about Aaron’s story and this innovative technology.

02/13/2026

Vanderbilt Health researchers have created a new way to connect genetic risk factors with how genes are controlled. This helps them find new genes that may play a role in colorectal cancer and could be targets for future treatments.

The study advances understanding of risk for colorectal cancer and points to targets for developing new treatments.

02/12/2026

For patients with liver‑limited cancers such as metastatic colorectal cancer, treatment options can be limited. Hepatic artery infusion (HAI) therapy offers a targeted way to deliver chemotherapy directly to the liver.

This therapy uses a surgically implanted pump to send high‑dose chemotherapy into the hepatic artery, which leads to the liver. The liver can process these higher doses more safely than with standard systemic chemotherapy treatment. This approach can be more effective in shrinking tumors, increase the chance of surgical removal, and lower the risk of the cancer returning in the liver.

Vanderbilt-Ingram Cancer Center is one of the few centers in the country with the experience needed to provide this therapy. Our team is also leading a national clinical trial for patients with unresectable colorectal liver metastases to help expand access to this option.

In this video, Dr. Kristen Ciambor and Dr. Sekhar Padmanabhan explain how the hepatic artery infusion pump works.

02/10/2026

On Monday night, several breast cancer survivors and patients from Vanderbilt‑Ingram Cancer Center were recognized as special guests at Vanderbilt University’s Women’s Basketball Play4Kay pink game.

From the moment they stepped onto the court, our survivors were welcomed with applause, encouragement and heartfelt support from the Vanderbilt community. For our survivors, the experience was more than simply being acknowledged at a game. It was a celebration of their strength, their journeys and the hope they carry forward.

We were grateful for the opportunity to celebrate them and to stand with them during such a meaningful evening. 🩷

02/10/2026

Aaron Davis invited us to be in the operating room as he became a milestone patient at Vanderbilt Health for a groundbreaking treatment. He's sharing his story as a chance to send a message.